A randomized, open label, single center, single-dose, cross-over study to determine the absolute bioavailability and the nasopharyngeal absorption of PMI-150 (intranasal ketamine) in healthy adult volunteers
Phase of Trial: Phase I
Latest Information Update: 09 Jan 2008
At a glance
- Drugs Ketamine; Ketamine; Ketamine
- Indications Acute pain; Cancer pain
- Focus Pharmacokinetics
- Sponsors Javelin Pharmaceuticals
- 09 Jan 2008 Status changed from recruiting to completed.
- 31 Aug 2007 New trial record.